NCT03881631

Brief Summary

This study will examine the effects of the Mindfulness-Based Stress Reduction (MBSR) program and the Living Well program, compared to a control group, to see if the programs might be associated with better immune function (response to current influenza vaccine), physical and emotional health, and well-being.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
142

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jul 2016

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 18, 2016

Completed
2.7 years until next milestone

First Submitted

Initial submission to the registry

March 15, 2019

Completed
4 days until next milestone

First Posted

Study publicly available on registry

March 19, 2019

Completed
4.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 3, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 3, 2023

Completed
Last Updated

May 8, 2023

Status Verified

May 1, 2023

Enrollment Period

6.8 years

First QC Date

March 15, 2019

Last Update Submit

May 5, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Antibody response to influenza vaccination

    Change in amount of antibody titers following influenza vaccination

    pre-vaccination to 6 weeks and 6 months post-vaccination

Secondary Outcomes (3)

  • Granzyme B (GrzB) activity after influenza vaccination

    pre-vaccination to 6 weeks and 6 months post-vaccination

  • Ratio of T-cell cytokines, interferon (IFN)-gamma and IL-10

    pre-vaccination to 6 weeks and 6 months post-vaccination

  • Inflammatory cytokines, interleukin (IL)-6 and tumor necrosis factor (TNF)-alpha

    baseline to 6 weeks to 6 months post-intervention

Study Arms (3)

Mindfulness Based Stress Reduction (MBSR) Program

EXPERIMENTAL

The MBSR program is an eight-week-long course designed to teach subjects how to develop their inner resources in the service of taking better care of themselves. MBSR training includes the learning and refining of a range of skills aimed at increasing relaxation and awareness of physical experiences and sensations related to physical symptoms, emotions, and thoughts. Special emphasis is placed on movement, meditation, and breathing.

Behavioral: Mindfulness Based Stress Reduction Program

Living Well (LW) Program

ACTIVE COMPARATOR

LW is an eight-week course of group presentations and discussions on topics related to the promotion of health and well-being in the context of dementia caregiving. LW is designed to teach participants how to improve their physical and emotional health as a complement to traditional medical treatments.

Behavioral: Living Well Program

Usual Care

NO INTERVENTION

The usual care arm is a no intervention group wherein participants experience their usual circumstances.

Interventions

Group-based intervention

Also known as: MBSR
Mindfulness Based Stress Reduction (MBSR) Program

Group-based intervention

Living Well (LW) Program

Eligibility Criteria

Age55 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • years of age and older
  • English-speaking (consent process and assessments will be conducted in English only)
  • Currently living with or in proximity to, and the primary caregiver for, a loved one with dementia who lives in the community-for the purposes of this study, "loved one" refers to a family member such as a spouse, ex-spouse, significant other, sibling, in-law, parent, or other type of close established relationship (e.g., close friend) regarded as family; "primary caregivers" provide daily informal (non-paid) in-person care.
  • Currently experiencing moderate to high levels of perceived stress (PSS-10 ≥ 12) and/or caregiver burden (MCSI ≥ 5)
  • Participants will be asked to stabilize medications prior to beginning the trial, and for the duration of the trial (If medication dose changes do occur, analytic models will include those changes as time-varying covariates)

You may not qualify if:

  • Loved one with dementia currently resides in a long-term care facility (e.g., nursing home) without the caregiver.
  • Modules from the Mini International Neuropsychiatric Exam (MINI 30) will be used to exclude subjects who have these psychiatric conditions: current alcohol dependence, current non-alcohol psychoactive substance use dependence, psychotic disorders (current and lifetime), bipolar disorder, and current mood disorder with psychotic features.
  • Subjects will also be excluded for the following reasons: having completed an MBSR program in the past; allergy to eggs (the influenza vaccine is most commonly manufactured using an egg-based process); history of Guillain-Barré syndrome; immunodeficiency or receipt of immunosuppressive therapy; recent major surgery; and active neoplastic disease.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Rochester Medical Center

Rochester, New York, 14642, United States

Location

MeSH Terms

Conditions

Stress, Psychological

Condition Hierarchy (Ancestors)

Behavioral SymptomsBehavior

Study Officials

  • Kathi L Heffner, PhD

    University of Rochester

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
FACTORIAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

March 15, 2019

First Posted

March 19, 2019

Study Start

July 18, 2016

Primary Completion

May 3, 2023

Study Completion

May 3, 2023

Last Updated

May 8, 2023

Record last verified: 2023-05

Data Sharing

IPD Sharing
Will share

Data sharing is in accordance with NIH Data Sharing Policy.

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
Time Frame
Within 12 months of study end

Locations